Late Insights into Early Origins of Disease
Open/View files
Date
2008
Author(s)
Publisher
Wiley-Blackwell
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Grandjean, Philippe. 2008. “Late Insights into Early Origins of Disease.” Basic & Clinical Pharmacology & Toxicology 102 (2) (January 22): 94–99. doi:10.1111/j.1742-7843.2007.00167.x.
Abstract
Burgeoning research into early functional programming has opened a new perspective of developmental origins of disease and organ dysfunction. In examining the roots of this emerging paradigm, it appears that crucial observations were made already 25 years ago. Clear examples include the discoveries of foetal alcohol syndrome, cancer in daughters whose mothers had used diethylstilbestrol during pregnancy, and neurotoxicity of lead and methylmercury. However, this research was often considered controversial, scientific conclusions were cautiously hedged, and stakeholders demanded replication in excess. Recognition of the new paradigm was therefore delayed, preventive interventions even further so. In hindsight, and in light of the precautionary principle, the adverse effects incurred on public health and the environment would call for responsible judgment to balance reasonable scientific scepticism against the risks associated with inaction. The traditional scientific scrutiny whether confidence limits include the possibility of no effect must be modified to allow consideration of the likelihood of worst-case scenarios. Additional emphasis should be placed on the question: What could be known, given our study opportunities and methodologies? Our late insights into the early disease origins may then benefit science as well as prevention.
Other Available Sources
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
Collection